Ascend Laboratories

DRONABINOL

  1. Home
  2.  / 
  3. Q Code
  4.  / DRONABINOL – Q0167

Manufacturer:

Ascend Laboratories

Name:

DRONABINOL

HCPCS Code Descriptor:

Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

Category:

Q Code

HCPCS:

Q0167

NDC(s):

67877-0755-60, 67877-0754-60, 67877-0753-60, 67877-0570-60, 67877-0569-60, 67877-0568-60, 53097-0571-60, 53097-0570-60, 53097-0569-60, 53097-0568-60, 00904-7145-04, 00904-7144-61

Primary Type:

Oncology-Anti-Emetic

Generic Status:

Multi-Source

Route of Administration:

Oral

About:

DRONABINOL is an Oncology-Anti-Emetic drug manufactured by Ascend Laboratories and administered via the Oral route of administration. The Q Code: Q0167 is aligned to the drug DRONABINOL.

Access Pricing and More By Registering

HCPCS Added Date:

4/1/98

HCPCS Effective Date:

4/1/98

HCPCS Short Description:

Dronabinol 2.5mg oral

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found